membrane metalloendopeptidase
| GO Term | Evidence Code | PMID |
|---|---|---|
| amyloid-beta clearance by cellular catabolic process | ||
| positive regulation of long-term synaptic potentiation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleoplasm | ||
| cytoplasm | ||
| early endosome | ||
| trans-Golgi network | ||
| centrosome |
| GO Term | Evidence Code | PMID |
|---|---|---|
| phosphatidylserine binding | ||
| endopeptidase activity | ||
| endopeptidase activity | ||
| endopeptidase activity | ||
| metallocarboxypeptidase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110160 | Charcot-Marie-Tooth disease axonal type 2T | |
| DOID:0111745 | cerebellar ataxia type 43 | |
| DOID:10652 | Alzheimer's disease | |
| DOID:10976 | membranous glomerulonephritis | |
| DOID:9246 | cerebral amyloid angiopathy |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026